Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis

被引：0
作者：
Patricia Pozo-Rosich
Karen H. Samaan
Todd J. Schwedt
Robert A. Nicholson
Mallikarjuna Rettiganti
Eric M. Pearlman
机构：
[1] Vall d’Hebron University Hospital,Headache Unit, Neurology Department
[2] Vall d’Hebron Research Institute,Headache and Neurological Pain Research Group, Department de Medicine
[3] Universitat Autònoma de Barcelona,undefined
[4] Eli Lilly and Company,undefined
[5] LTC-South,undefined
[6] Mayo Clinic,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Chronic; Efficacy; Episodic; Galcanezumab; Migraine; Wear off;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3154 / 3165
页数：11
相关论文
共 24 条
  • [1] Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis
    Pozo-Rosich, Patricia
    Samaan, Karen H.
    Schwedt, Todd J.
    Nicholson, Robert A.
    Rettiganti, Mallikarjuna
    Pearlman, Eric M.
    ADVANCES IN THERAPY, 2021, 38 (06) : 3154 - 3165
  • [2] Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial
    Shibata, Mamoru
    Nihira, Atsuko
    Tanji, Yuka
    Ozeki, Akichika
    Imagawa, Hideyuki
    Komori, Mika
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 2007 - 2019
  • [3] Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial
    Mamoru Shibata
    Atsuko Nihira
    Yuka Tanji
    Akichika Ozeki
    Hideyuki Imagawa
    Mika Komori
    Neurology and Therapy, 2023, 12 : 2007 - 2019
  • [4] Safety and efficacy of galcanezumab in Taiwanese patients: a post-hoc analysis of phase 3 studies in episodic and chronic migraine
    Yang, Chun-Pai
    Lee, Chia-Fang
    Dell'Agnello, Grazia
    Hundemer, Hans-Peter
    Lipsius, Sarah
    Wang, Shuu-Jiun
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (10) : 1653 - 1666
  • [5] Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis
    Goadsby, Peter J.
    Dodick, David W.
    Martinez, James M.
    Ferguson, Margaret B.
    Oakes, Tina M.
    Zhang, Qi
    Skljarevski, Vladimir
    Aurora, Sheena K.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (08) : 939 - 944
  • [6] Sustained response of galcanezumab in migraine prevention: Patient--level data from a post hoc analysis in patients with episodic or chronic migraine
    Tepper, Stewart J.
    Dong, Yan
    Vincent, Maurice
    Wietecha, Linda A.
    HEADACHE, 2023, 63 (10): : 1380 - 1390
  • [7] Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial
    Kim, Byung-Kun
    Cho, Soo-Jin
    Han, Jeong Hee
    Dell'Agnello, Grazia
    Panni, Tommaso
    Kim, Manho
    Oh, Kyungmi
    Moon, Heui-Soo
    Chu, Min Kyung
    JOURNAL OF CLINICAL NEUROLOGY, 2023, 19 (05): : 483 - 494
  • [8] Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials
    Zaazouee, Mohamed Sayed
    Ebrahim, Rokaya Y.
    Al-araj, Ghaida'a
    Zaki, Ibram
    Saad, Ahmed
    Farhat, Abdullah Mohamed
    Ali, Mustafa Hussein
    Elshennawy, Mohamed
    Fawy, Omar Khaled Fahmy
    Ahmed, Hadi F.
    Alahmad, Ziad
    Nada, Eman Ayman
    Abo-Hamra, Reem I.
    Elsnhory, Ahmed Bostamy
    Eleyan, Mohammed
    AbuEl-Enien, Hazem
    Elromely, Rasha Abdo
    AbdelQadir, Yossef Hassan
    Shah, Jaffer
    Elshanbary, Alaa Ahmed
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2024, 60 (01):
  • [9] Annual indirect costs savings in patients with episodic or chronic migraine: a post-hoc analysis of phase 3 galcanezumab clinical trials in the United States
    Varnado, Oralee J.
    Ye, Wenyu
    Mi, Xiaojuan
    Burge, Russel
    Hall, Jerry
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 149 - 157
  • [10] Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study
    Lipton, Richard B.
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez Campos, Verena
    Halker Singh, Rashmi B.
    Ailani, Jessica
    HEADACHE, 2020, 60 (10): : 2444 - 2453
123